Literature DB >> 15131682

The Amsler chart is of doubtful value in retinal screening for early laser therapy of subretinal membranes. The West London Survey.

F H Zaidi1, R Cheong-Leen, E J Gair, R Weir, E Sharkawi, N Lee, K Gregory-Evans.   

Abstract

PURPOSE: Validating the current protocol of Amsler chart grid surveillance for the early detection of subretinal neovascular membrane(SRN) in age-related macular degeneration(AMD), and investigating its value in facilitating early laser therapy.
METHODS: A retrospective pilot study.
SETTING: Central London eye hospital with dedicated 24-h ophthalmic casualty serving West and West-central London. PARTICIPANTS: 100 consecutive AMD patients who attended casualty with vision loss fulfilling the following criteria: patients had received and been instructed in the use of Amsler charts according to the unit's dispensation protocol,fluorescein angiography which confirmed new SRN. Patients presented over 20 months. Outcome measures were detection of SRN by the Amsler chart, and laser treatment of SRN.
RESULTS: The Amsler chart surveillance protocol had detected SRN in 29 of the 100 patients. The surveillance protocol detected less than 30% of the specific patients who subsequently underwent laser treatment. A statistically significant difference was seen on comparing the ages of patients in whom the screening protocol was successful versus those in whom it was unsuccessful (student's t-test,P<3.2 x 103). Younger patients were more likely to be detected using the Amsler chart. A one-tailed Z2 test approached, but did not achieve, statistical significance (Z2 = 1.057,P <0.3) suggesting that patients who have already lost vision to SRN in one eye might not be more likely to be detected using the surveillance protocol than patients in whom SRN was affecting their first eye. In all, 38% of surveillance responders went on to receive laser therapy, compared with 37% of surveillance nonresponders.
CONCLUSIONS: The current Amsler chart surveillance protocol is suboptimal for detecting SRN in AMD, and a proportion of cases suitable for early laser therapy may be missing rapid detection. The results are especially important since recent advances in laser therapy for SRN require early detection for optimal effectiveness.

Entities:  

Mesh:

Year:  2004        PMID: 15131682     DOI: 10.1038/sj.eye.6700708

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  10 in total

Review 1.  The Amsler chart: absence of evidence is not evidence of absence.

Authors:  Michael Crossland; Gary Rubin
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

2.  Subretinal membranes are associated with abnormal degrees of pupil "evasion": an index of clinical macular dysfunction.

Authors:  F H Zaidi; F D Bremner; K Gregory-Evans; K D Cocker; M J Moseley
Journal:  Br J Ophthalmol       Date:  2006-09       Impact factor: 4.638

3.  Assessment of visual distortions in age-related macular degeneration: emergence of new approaches.

Authors:  Noelia Pitrelli Vazquez; Paul C Knox
Journal:  Br Ir Orthopt J       Date:  2015

4.  Improved Adherence to Vision Self-monitoring with the Vision and Memory Stimulating (VMS) Journal for Non-neovascular Age-related Macular Degeneration during a Randomized Controlled Trial.

Authors:  Ava K Bittner; Sheryl Torr-Brown; Ellen Arnold; Antonia Nwankwo; Patricia Beaton; Radhika Rampat; Gislin Dagnelie; Mark Roser
Journal:  J Clin Exp Ophthalmol       Date:  2014-01-22

Review 5.  Strategies for improving early detection and diagnosis of neovascular age-related macular degeneration.

Authors:  Pearse A Keane; Gabriella de Salvo; Dawn A Sim; Srini Goverdhan; Rupesh Agrawal; Adnan Tufail
Journal:  Clin Ophthalmol       Date:  2015-02-17

Review 6.  Early detection of age related macular degeneration: current status.

Authors:  Roy Schwartz; Anat Loewenstein
Journal:  Int J Retina Vitreous       Date:  2015-12-01

7.  Investigation of time to first presentation and extrahospital factors in the treatment of neovascular age-related macular degeneration: a retrospective cross-sectional study.

Authors:  Peng Yong Sim; Sonul Gajree; Baljean Dhillon; Shyamanga Borooah
Journal:  BMJ Open       Date:  2017-12-10       Impact factor: 2.692

8.  Presymptomatic Retinal Sensitivity Changes in Intermediate Age-Related Macular Degeneration Associated With New Retinal Fluid.

Authors:  Antony J Wightman; Carla J Abbott; Myra B McGuinness; Emily Caruso; Robyn H Guymer; Chi D Luu
Journal:  Transl Vis Sci Technol       Date:  2019-11-12       Impact factor: 3.283

9.  Real-Life Value of the Odysight® Application in At-Home Screening for Exudative Recurrence of Macular Edema.

Authors:  Gauthier Kielwasser; Laurent Kodjikian; Corinne Dot; Carole Burillon; Philippe Denis; Thibaud Mathis
Journal:  J Clin Med       Date:  2022-08-26       Impact factor: 4.964

10.  Home Monitoring of Retinal Sensitivity on a Tablet Device in Intermediate Age-Related Macular Degeneration.

Authors:  Matthew Adams; Chi Yun Doreen Ho; Elizabeth Baglin; Pyrawy Sharangan; Zhichao Wu; David J Lawson; Chi D Luu; Andrew Turpin; Allison M McKendrick; Robyn H Guymer
Journal:  Transl Vis Sci Technol       Date:  2018-10-29       Impact factor: 3.283

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.